Cosmetic cross-reference

Calcium Citrate

CAS 813-94-5

Calcium Citrate (CAS 813-94-5) is a Phase 3 pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Calcium Citrate
CAS Number
813-94-5
UNII
86117BWO7P
InChIKey
FNAQSUUGMSOBHW-UHFFFAOYSA-H
ChEMBL ID
CHEMBL2106123
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3
Late-stage clinical development phase from the compound identifier source.
ChEMBL CHEMBL2106123 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE DrugCentral 33 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Recalled product 49 215.513 10080231
Hypocalcaemia 58 76.067 10020947
Macular degeneration 41 65.55 10025409
Gouty tophus 10 42.617 10018641
Osteocalcin decreased 6 34.339 10050940
Toxicity to various agents 6 34.21 10070863
Fatigue 250 30.316 10016256
Spirometry abnormal 9 29.727 10041630
Chronic sinusitis 20 29.28 10009137
Atypical femur fracture 14 29.182 10070884
Dust allergy 10 28.455 10077439
Muscle spasms 73 28.122 10028334
Mite allergy 9 26.634 10077290
Paraesthesia oral 22 26.386 10057372
Dyspepsia 53 26.257 10013946
Mycotic allergy 9 25.07 10052758
Osteoarthritis 47 24.863 10031161
Drug interaction 11 24.783 10013710
Conjunctivitis allergic 9 22.748 10010744
Polyomavirus-associated nephropathy 12 22.578 10065381
Procedural pain 21 22.539 10064882
Diarrhoea 208 21.778 10012735
Product dose omission issue 86 19.934 10084406
Osteoporosis 32 19.491 10031282
Hypervitaminosis D 4 18.595 10020917
Full blood count abnormal 26 18.313 10017412
Stress fracture 12 18.262 10042212
Osteomalacia 7 17.823 10031250
Blood calcium abnormal 7 17.235 10005393
Blood calcium increased 13 16.828 10005396
Contraindicated product administered 5 16.64 10078504
Restless legs syndrome 18 16.443 10058920
Gingival disorder 9 15.975 10018280

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
calcium citrate 47613 SU MTHSPL
calcium citrate 47613 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Calcium Citrate used for in pharmaceutical contexts?

Calcium Citrate (CAS 813-94-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Calcium Citrate?

Calcium Citrate has 0 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Recalled product, Hypocalcaemia, Macular degeneration, Gouty tophus, Osteocalcin decreased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Calcium Citrate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Calcium Citrate with EU status "permitted".

What clinical phase is Calcium Citrate in?

Calcium Citrate is rendered with ChEMBL max phase 3.